Literature DB >> 29791830

Learning from a Trial Stopped by a Data and Safety Monitoring Board.

David Harrington1, Jeffrey M Drazen1.   

Abstract

Mesh：

Year:  2018        PMID： 29791830     DOI： 10.1056/NEJMe1805123

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Focus on extracorporeal life support.

Authors:  Peter Schellongowski; Alain Combes; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2018-11-21       Impact factor: 17.440

2.  Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack.

Authors:  Richard F Schlenk; Sonia Jaramillo; Carsten Müller-Tidow
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

Review 3.  Extracorporeal membrane oxygenation as rescue therapy for severe hypoxemic respiratory failure.

Authors:  Bhoumesh Patel; Subhasis Chatterjee; Seanna Davignon; J Patrick Herlihy
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 4.  Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.

Authors:  Corrado Pelaia; Cecilia Calabrese; Rosa Terracciano; Francesco de Blasio; Alessandro Vatrella; Girolamo Pelaia
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

Review 5.  Current and evolving standards of care for patients with ARDS.

Authors:  Mario Menk; Elisa Estenssoro; Sarina K Sahetya; Ary Serpa Neto; Pratik Sinha; Arthur S Slutsky; Charlotte Summers; Takeshi Yoshida; Thomas Bein; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2020-11-06       Impact factor: 17.440

Review 6.  Extracorporeal life support for adults with acute respiratory distress syndrome.

Authors:  Alain Combes; Matthieu Schmidt; Carol L Hodgson; Eddy Fan; Niall D Ferguson; John F Fraser; Samir Jaber; Antonio Pesenti; Marco Ranieri; Kathryn Rowan; Kiran Shekar; Arthur S Slutsky; Daniel Brodie
Journal:  Intensive Care Med       Date:  2020-11-02       Impact factor: 17.440

7.  Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approach.

Authors:  Markus Harboe Olsen; Mathias Lühr Hansen; Sanam Safi; Janus Christian Jakobsen; Gorm Greisen; Christian Gluud
Journal:  BMC Med Res Methodol       Date:  2021-07-31       Impact factor: 4.615
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.